Textbook Notes (368,035)
Canada (161,583)
Psychology (1,957)
PS268 (56)
Chapter 8

Drugs and Behaviour - Chapter 8.docx

7 Pages
171 Views
Unlock Document

Department
Psychology
Course
PS268
Professor
Bruce Mc Kay
Semester
Winter

Description
Drugs and Behaviour - Chapter 8  Mental Illness o Referred to as psychological disorders, characterized by alterations in thinking, mood or behaviour  Associated with significant distress and impaired functioning  Can vary from mild to severe o Second leading cause of human disability and premature death in Canada o Depression occurs in 10-25% of females (twice the rate in men) o In people with mental disorders, substance abuse risk is 2-4x as high as general population  Tobacco and cannabis the two most abused o Risk of schizophrenia in adulthood 6x as high in frequent cannabis users o Two proposed theories  Self medication hypothesis  People choose drug that is effective in combating symptoms of psychosis o Provides negative reinforcement  Primary addiction hypothesis  Neurobiology of psychosis and brain areas involved increase vulnerability to substance abuse  Increased vulnerability may produce increased pleasure o Provides positive reinforcement o Medical model th  Before 19 century, mental illness explained by magic or religious explanations or biophysical explanations  Increasing focus on neurobiological cause had beneficial results  Promoted new treatments, reduced stigma and encouraged investment into further research  Term “mental illness” implies particular model for behavioural disorders or dysfunctions  Medical model  Attacked by psychologists and psychiatrists  Patient appears with a set of symptoms, and on the basis of these symptoms a diagnosis is made as to which disease the patient has o Once disease is known, cause can be determined, and cure can be provided  A set of behavioural symptoms is all we have to define and diagnose the disorder  Do people really have a disease with a physical cause and a potential cure? Or is it similar to being described as “friendly”, “crabby”…etc?  Affects thinking, mood or behaviour  Can be associated with distress and impairment of function  Symptoms vary from mild to severe and may require hospitalization  If chemicals can normalize an individual’s behaviour, natural assumption would be that original problem due to chemical imbalance in the brain o Classification of mental disorders  Human behaviour is variable, and cause of mental disorder is unknown, classification of people with mental illnesses into categories is difficult  Psychotherapeutic drugs  Some division important for understanding the uses  DSM provides criteria for classifying mental disorders into hundreds of specific diagnostic categories o Become standard for mental health professionals  Anxiety is normal, but when they become unrealistic, they can interfere with daily life  Physical symptoms may also be present o Referred to as “anxiety disorders” Brian Kwok 1 Drugs and Behaviour - Chapter 8  Tend to not think of anxiety as a behavioural system, but an internal state that causes the disorders  Linked with many disorders, reason why anti-anxiety drugs are applicable to multiple illnesses  Psychosis  Serious mental disorder involving loss of contact with reality  Major disturbance of normal intellectual and social functioning o Not knowing current date, hearing voices and withdrawal from reality  Individuals exhibit perturbations in mood and emotion secondary to alterations in limbic system function  May be viewed as group of symptoms that can have many possible causes  Organic psychoses o One that has known physical cause  Functional psychoses o No known or obvious physical cause  Schizophrenia – shattered mind, not split personality  Mood disorders  Appearance of depressed or manic symptoms  Have no single cause, several factors o Biochemical imbalance in brain, psychological factors and socioeconomic factors  Important distinction is in the drug treatment of mood disorders o Bipolar – manic and depressive episodes o Major depression – only depressive episodes are reported  Anxiety and panic disorders  Panic attacks o Shortness of breath, dizziness, palpitations or accelerated heart rate, trembling, seating, choking, numbness, fear of dying or fear of going crazy  Cholecystokinin plays fundamental role in panic that can be modelled in animals o Can cause panic attacks  People anxiety disorder are sensitive to CCK  May have higher levels in brain  Anxiety and depression important to development of panic disorder  Many different classifications of panic disorder  Many factors that influence pharmacological management of panic o Different psychotherapeutics can be prescribed  Children of adults with anxiety disorders much greater risk of an anxiety disorder than general population o Genetic factor, effect of parenting practices or both  Assigning a diagnosis based off of experience and observation, two diagnosis can be completely different  Treatment of mental disorders o Before 1950  1917 – physical treatment predominant  Great proportion of patients had general paresis – syphilitic infection of the nervous system  Malaria related fever produced marked improvement  1920s – wealthier patients could afford barbiturates and other depressant  Reduction in psychotherapy would enable people to express thoughts better  1933 – Manfred Sakel induced comas in schizophrenics Brian Kwok 2 Drugs and Behaviour - Chapter 8  1932 – Ladislas von Meduna believed that epileptics could not have schizophrenia and vice versa  1930-1940s – Electroconvulsive Therapy – passing electrical currents through brain to trigger seizures  1980s – ECT used when drugs failed to achieve satisfactory response  Use higher among individuals who had comorbid symptoms of depression  Antipsychotics drugs still first choice for schizophrenia treatment  ECT still widely used with severely depressed patients who do not respond to medication  Controversial treatment o Antipsychotics  Phenothiazines – special properties when used by people with mental illnesses  Chlorpromazine did not by itself induce drowsiness or loss of consciousness, made patients unconcerned about upcoming surgery  Referred to as tranquilizers  Neuroleptic – taking hold of the nervous system  Antipsychotics – reflects ability to reduce psychotic symptoms without producing drowsiness and sedation  Treatment effects and considerations  Increase in sophistication of experimental programs that evaluate effectiveness of various drugs  Phenothiazines far from perfect, but better than placebo treatments  Another method to determine effectiveness is determining the incidence of relapse or symptom recurrence  Since 1950 – many new phenothiazines introduced and several completely new types of antipsychotics drugs discovered o Target positive symptoms  Agitation, aggression, delusions and hallucination o Negative symptoms  Social withdrawal, lack of motivation, impaired cognition  First-generation antipsychotics o Classified b their chemical structure o Dopamine D2 receptor binding affinity  Second-generation antipsychotics o Greater serotonin affinity relative to dopamine D2 receptor affinity o 1990s – atypical anti-psychotic agents (second-generation)  Became available on Canadian Market for treatment o Not without side effects  Using ATA in treating children increasing exponentially, raising concerns of appropriateness  No approved indications for ATA use in children and adolescents in Canada  Mechanism of antipsychotic action  All phenothiazines and other first-generations produce pseudoparinsonism o Exhibit symptoms similar to Parkinson’s  Known to be caused by loss of dopamine neurons o Block other types of receptors as well  Clozapine (second generation) different from other antipsychotics o Produced much less psuedoparkinsonism o Worked when some of the other antipsychotics didn’t o Risk of producing deadly white blood cell production suppression Brian Kwok 3 Drugs and Behaviour - Chapter 8  Risperidone, olanzeine and other second generations referred to as serotonin dopamine antagonists o Reduces positive symptoms of schizophrenia o Improving negative symptoms  Side effects of antipsycho
More Less

Related notes for PS268

Log In


OR

Join OneClass

Access over 10 million pages of study
documents for 1.3 million courses.

Sign up

Join to view


OR

By registering, I agree to the Terms and Privacy Policies
Already have an account?
Just a few more details

So we can recommend you notes for your school.

Reset Password

Please enter below the email address you registered with and we will send you a link to reset your password.

Add your courses

Get notes from the top students in your class.


Submit